• Profile
Close

Characteristics and outcomes of patients ≤ 75 years who underwent transcatheter aortic valve implantation: Insights from the SOURCE 3 Registry

Clinical Research in Cardiology Dec 19, 2018

Frank D, et al. - Patients < 75 years old who underwent transcatheter valve implantation (TAVI) in the SAPIEN 3 European post-approval SOURCE 3 Registry were investigated for comorbidities and were analysed for outcomes at 30 days and 1 year. Researchers analyzed 3 age groups of patients for outcomes and characteristics: < 75 (n = 235), 75–80 (n = 391) and ≥ 80 years (n = 1320). They observed that patients younger than 75 years are a minority (12%) in current TAVI practice. This cohort had comorbidities that did not account for by traditional surgical risk scores despite younger age and lower surgical risk scores.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay